UNSPSC 51281801: Idarubicin

This classification denotes an anthracycline antibiotic with the molecular formula C26H27NO9, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZRP63D75JW, chemically known as 5,12-naphthacenedione, 9-acetyl-7-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,9,11-trihydroxy-, (7s-cis)- but generally known as idarubicin, which bears US NIH Compound Identifier 42890. European Medicines Agency schedules Idarubicin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08111MIG.

UNSPSC 51281801 Idarubicin is a Commodity code for a specific chemotherapy pharmaceutical product, yet recent state and local procurement activity under this code does not reflect idarubicin procurement. State and local health departments and county health systems are instead using the code to solicit related pharmaceutical products and medical supplies through competitive bidding and cooperative purchasing vehicles. The actual work being bought includes pharmaceutical warehouse orders routed through multi-agency consortia and direct procurement of emergency-response medications and medical equipment. Issuing bodies include state health departments and county health authorities conducting procurements via IFB and piggyback arrangements.

Illinois Department of Public Health awarded a piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC (Solicitation 26482DPHPREPDB53392, posted August 28, 2026, response deadline September 11, 2026) valued at $2,999,999.11 over the contract life for supply of Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets with a 12-month initial term and two optional renewal years. Seminole County, Florida posted an IFB for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually (Solicitation IFB60459723LAS, posted June 30, 2026) with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida and an initial two-year contract term plus one optional renewal year. Recent activity appears concentrated in Florida and Illinois, though the code mismatch between the idarubicin commodity designation and the antibiotic and emergency-response medications actually being solicited suggests either category misalignment in state procurement systems or a broader aggregation of pharmaceutical supply categories under a single code.